Novocol Pharmaceutical of Canada Inc.: federal grants and contributions: 2 agreements; $33.2M value; 2 departments; 2 programs.
Assay record ASY-CA-1UJ5DPF0FS · Cite as: Assay Systems, “Novocol Pharmaceutical of Canada Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/novocol-pharmaceutical-of-canada-inc/
This project will support the expansion of existing bio-manufacturing facilities and increasing fill-finish capacity for vaccines/therapies, including live and viral vector vaccines.
Design of a facility, inclusive of engineering design and research in innovative formulation and fill-finish manufacturing of vaccines, therapies and other biopharmaceuticals using a Ready-To-Use (RTU) container platform for vials and prefilled syringes. Novocol Pharma is a world-class commercial aseptic fill-finish operation with multiple fill-finish suites and scientific/technical support departments (Microbiology, Chemistry, Product Development, Engineering, Validation, Stability and Analytical Services). An existing warehouse building will be renovated to create injectable vaccine/therap
All grants from Innovation, Science and Economic Development Canada
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.